These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 29111371)

  • 1. Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.
    Wang D; Zhang Q; Hu X; Wang W; Zhu X; Yuan Z
    Acta Biomater; 2018 Jan; 65():327-338. PubMed ID: 29111371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of a Bifunctional Aβ Aggregation Inhibitor with the Abilities of Antiamyloid-β and Copper Chelation.
    Zhang Q; Hu X; Wang W; Yuan Z
    Biomacromolecules; 2016 Feb; 17(2):661-8. PubMed ID: 26756252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity.
    Hu X; Zhang Q; Wang W; Yuan Z; Zhu X; Chen B; Chen X
    ACS Chem Neurosci; 2016 Sep; 7(9):1255-63. PubMed ID: 27433833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RTHLVFFARK-NH
    Meng J; Zhang H; Dong X; Liu F; Sun Y
    J Inorg Biochem; 2018 Apr; 181():56-64. PubMed ID: 29407908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric bis (heptyl)-Cognitin Blocks Alzheimer's β-Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils.
    Hu SQ; Wang R; Cui W; Mak SH; Li G; Hu YJ; Lee MY; Pang YP; Han YF
    CNS Neurosci Ther; 2015 Dec; 21(12):953-61. PubMed ID: 26507365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amentoflavone: A Bifunctional Metal Chelator that Controls the Formation of Neurotoxic Soluble Aβ
    Sun L; Sharma AK; Han BH; Mirica LM
    ACS Chem Neurosci; 2020 Sep; 11(17):2741-2752. PubMed ID: 32786307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.
    Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
    J Alzheimers Dis; 2004 Oct; 6(5):515-25. PubMed ID: 15505374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. d-Enantiomeric RTHLVFFARK-NH
    Liu W; Dong X; Sun Y
    ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Tripeptide-Based Inhibitor of Multifaceted Amyloid β Toxicity.
    Rajasekhar K; Madhu C; Govindaraju T
    ACS Chem Neurosci; 2016 Sep; 7(9):1300-10. PubMed ID: 27355515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and bio-activities of bifunctional tetrahydrosalen Cu (II) chelators with potential efficacy in Alzheimer's disease therapy.
    Sun B; Jiang H
    J Inorg Biochem; 2024 Oct; 259():112636. PubMed ID: 38943843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gold nanoparticle-capped mesoporous silica-based H
    Yang L; Yin T; Liu Y; Sun J; Zhou Y; Liu J
    Acta Biomater; 2016 Dec; 46():177-190. PubMed ID: 27619837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-amyloid fibrils in Alzheimer disease are not inert when bound to copper ions but can degrade hydrogen peroxide and generate reactive oxygen species.
    Mayes J; Tinker-Mill C; Kolosov O; Zhang H; Tabner BJ; Allsop D
    J Biol Chem; 2014 Apr; 289(17):12052-12062. PubMed ID: 24619420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N,N'-1,10-Bis(Naringin) Triethylenetetraamine, Synthesis and as a Cu(II) Chelator for Alzheimer's Disease Therapy.
    Guo LX; Sun B
    Biol Pharm Bull; 2021 Jan; 44(1):51-56. PubMed ID: 33162492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.
    Ono K; Naiki H; Yamada M
    Curr Pharm Des; 2006; 12(33):4357-75. PubMed ID: 17105432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cu
    Du C; Feng W; Dai X; Wang J; Geng D; Li X; Chen Y; Zhang J
    Small; 2022 Sep; 18(39):e2203031. PubMed ID: 36008124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.
    Yan P; Hu X; Song H; Yin K; Bateman RJ; Cirrito JR; Xiao Q; Hsu FF; Turk JW; Xu J; Hsu CY; Holtzman DM; Lee JM
    J Biol Chem; 2006 Aug; 281(34):24566-74. PubMed ID: 16787929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
    Tõugu V; Tiiman A; Palumaa P
    Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Water-Soluble Peptoid Chelator that Can Remove Cu
    Behar AE; Sabater L; Baskin M; Hureau C; Maayan G
    Angew Chem Int Ed Engl; 2021 Nov; 60(46):24588-24597. PubMed ID: 34510664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power of Dopamine: Multifunctional Compound Assisted Conversion of the Most Risk Factor into Therapeutics of Alzheimer's Disease.
    Gharai PK; Khan J; Pradhan K; Mallesh R; Garg S; Arshi MU; Barman S; Ghosh S
    ACS Chem Neurosci; 2024 Jul; 15(13):2470-2483. PubMed ID: 38874606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.